Cargando…
Perioperative rifaximin is not associated with enhanced functional and volumetric recovery after major liver resection
The objective of this randomized controlled trial (RCT) was to assess the impact of rifaximin on the course of liver function, liver regeneration and volumetric recovery in patients undergoing major hepatectomy. The ARROW trial was an investigator initiated, single-center, open-label, phase 3 RCT wi...
Autores principales: | Bednarsch, Jan, Czigany, Zoltan, Loosen, Sven H., Heij, Lara, Ruckgaber, Lorenz, Maes, Henning, Krause, Jan-Pit, Reen, Matthias, Toteva, Beata, Vosdellen, Theresa, Bruners, Philipp, Lang, Sven Arke, Ulmer, Tom Florian, Roderburg, Christoph, Luedde, Tom, Neumann, Ulf Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429542/ https://www.ncbi.nlm.nih.gov/pubmed/34504196 http://dx.doi.org/10.1038/s41598-021-97442-w |
Ejemplares similares
-
Prognostic evaluation of HCC patients undergoing surgical resection: an analysis of 8 different staging systems
por: Bednarsch, Jan, et al.
Publicado: (2020) -
The role of tumor-infiltrating lymphocytes in cholangiocarcinoma
por: Liu, Dong, et al.
Publicado: (2022) -
Leakage and Stenosis of the Hepaticojejunostomy Following Surgery for Perihilar Cholangiocarcinoma (†)
por: Bednarsch, Jan, et al.
Publicado: (2020) -
Bacterial bile duct colonization in perihilar cholangiocarcinoma and its clinical significance
por: Bednarsch, Jan, et al.
Publicado: (2021) -
Compelling Long-Term Results for Liver Resection in Early Cholangiocarcinoma
por: Bednarsch, Jan, et al.
Publicado: (2021)